NANOG and Alzheimer disease: Quantification of the 14 449 NANOGP8 peaks that overlapped with sites occupied by FOXA1, AR and/or NKX3.1 in the presence (Figure 3e) or absence (Supplementary Figure S3C) of androgen demonstrated that AR-binding sites encompassed the largest proportion (~71%) of NANOG-occupied regions under AD conditions (Figure 3e), whereas FOXA1-binding sites encompassed the largest proportion (~71%) of NANOG-occupied regions under AI conditions (Supplementary Figure S3C).